Number of the records: 1  

Purification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoan Leishmania tarentolae

  1. 1.
    SYSNO ASEP0347295
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePurification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoan Leishmania tarentolae
    Author(s) Gazdag, E. M. (DE)
    Cirstea, I. (DE)
    Breitling, R. (DE)
    Lukeš, Julius (BC-A) RID, ORCID
    Blankenfeldt, W. (DE)
    Alexandrov, K. (AU)
    Source TitleActa Crystallographica Section F-Structural Biology and Crystallization Communications. - : Wiley - ISSN 1744-3091
    Roč. 66, č. 8 (2010), s. 871-877
    Number of pages7 s.
    Languageeng - English
    CountryGB - United Kingdom
    Keywordsrecombinant proteins ; eukaryotic expression systems ; Leishmania
    Subject RIVEB - Genetics ; Molecular Biology
    CEZAV0Z60220518 - PAU-O, BC-A (2005-2011)
    UT WOS000280708200002
    DOI10.1107/S1744309110019330
    AnnotationThe rapid and inexpensive production of high-quality eukaryotic proteins in recombinant form still remains a challenge in structural biology. Here, a protein-expression system based on the protozoan Leishmania tarentolae was used to produce human Cu/Zn superoxide dismutase (SOD1) in recombinant form. Sequential integration of the SOD1 expression cassettes was demonstrated to lead to a linear increase in expression levels to up to 30 mg per litre. Chromatographic purification resulted in 90% pure recombinant protein, with a final yield of 6.5 mg per litre of culture. The protein was crystallized and the structures of two new crystal forms were determined. These results demonstrate the suitability of the L. tarentolae expression system for structural research.
    WorkplaceBiology Centre (since 2006)
    ContactDana Hypšová, eje@eje.cz, Tel.: 387 775 214
    Year of Publishing2011
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.